aTYR PHARMA INC (ATYR) stock forecast and price target
Price $6.11 · data as of November 13, 2026
12-month price target
Average target$45.17
Upside / downside+639.8%
Analysts6
ConsensusHold
Low $5.00Average $45.17High $160.00
Gold marker: average target · white marker: today’s price ($6.11)
Analyst ratings
Strong buy 2Buy 1Hold 6Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-23.97 | +22.9% | $0 |
| Next fiscal year ends December 31, 2027 | $-114.76 | −426.4% | $0 |
| Next quarter ends December 31, 2026 | $-39.16 | −706.4% | $0 |
| Quarter after ends March 31, 2027 | $-74.50 | −2411.8% | $0 |
Consensus of the analysts covering aTYR PHARMA INC, updated daily. In the last 30 days 2 estimates were raised and 1 lowered.
Frequently asked questions
What is the aTYR PHARMA INC stock price target?
The average 12-month target from 6 analysts is $45.17, 639.8% above the current price of $6.11 Targets range from $5.00 to $160.00.
Is aTYR PHARMA INC a buy according to analysts?
The consensus rating is “Hold” (2 strong buy, 1 buy, 6 hold). Ratings are opinions, not guarantees; this is not investment advice.
How much is aTYR PHARMA INC expected to earn?
Analysts expect EPS of $-23.97 for the fiscal year ending December 31, 2026 and $-114.76 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.